Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...

NORTH PHILADELPHIA (WPVI) -- Cases of type 2 diabetes are increasing so quickly that the CDC predicts 40% of Americans and more than half of all African-Americans and Latinos will develop it in their ...

Much excitement has built in recent years on the new class of incretin drugs that include glucagon-like-peptide-1 inhibitor (single agonists such as semaglutide) and also dual glucose-dependent ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

Detailed price information for Biomea Fusion Inc (BMEA-Q) from The Globe and Mail including charting and trades.

People with type 2 diabetes usually have a higher risk of pancreatic cancer compared with people without type 2 diabetes. But that risk may depend on how long you’ve had type 2 diabetes. People who ...

GLP-1 receptor agonists and dual agonists, such as semaglutide and tirzepatide, have become powerful tools for managing type 2 diabetes. But, like any medication, they come with side effects. From ...

An alarming rise in youth diabetes. Learn the causes, symptoms, and risk factors of type 2 diabetes affecting young people under 30 as explained by an endocrinologist ...

Biomea Fusion ( NASDAQ: BMEA) shares rose after reporting positive results from its mid-stage study testing icovamenib in ...

A macro calculator can help you build balanced meals for type 2 diabetes, and registered dietitian Dalina Soto shares how to adapt the numbers to your everyday foods. Managing meals to keep blood ...

Most people know there are two types of diabetes—type 1 and type 2. Knowing which one you have matters quite a lot for how you treat them. But what you may not know about is a lesser-known variation ...